-
公开(公告)号：US20220111127A1
公开(公告)日：2022-04-14
申请号：US17559403
申请日：2021-12-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Sandra Nagale , Mark W. Boden , Andrew Dolan
Abstract: In some aspects, the present invention provides surgical procedures that comprise applying compositions into and/or onto tissue, including supporting tissues (e.g., ligaments, connective tissue, muscles, etc.) for pelvic organs, among other tissues. In other aspects, the present disclosure pertains to compositions that are useful for performing such procedures. In still other aspects, the present disclosure pertains to kits that are useful for performing such procedures.
-
公开(公告)号：US10827939B2
公开(公告)日：2020-11-10
申请号：US15227758
申请日：2016-08-03
Applicant: Boston Scientific Scimed, Inc.
Inventor： Sandra Nagale , Bryan Clark , Allan Shuros , Ding He , Dennis Werner , Lynne Swanson , Charles Gibson , Amedeo Chiavetta , Michael Peterson , Shibaji Shome , Mark Boden , Timothy Harrah
Abstract: The present disclosure relates to the field of tissue mapping and ablation. Specifically, the present disclosure relates to expandable medical devices for identifying and treating local anatomical abnormalities within a body lumen. More specifically, the present disclosure relates to systems and methods of focal treatment for overactive bladders.
-
公开(公告)号：US20200297409A1
公开(公告)日：2020-09-24
申请号：US16890395
申请日：2020-06-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Thomas John Herbst , Mark W. Boden , Sandra Nagale
IPC: A61B18/14
Abstract: In one aspect, the present disclosure is directed to methods of treating various conditions including bladder conditions in a patient, comprising: positioning at least one ablative element of an ablative device on or over an adventitial surface of the bladder; and using the ablative device to denervate bladder nerve fibers. Other aspects of the present disclosure pertain, for example, to devices and kits for of treating bladder conditions.
-
公开(公告)号：US10695128B2
公开(公告)日：2020-06-30
申请号：US15130644
申请日：2016-04-15
Applicant: Boston Scientific Scimed, Inc.
Inventor： Sandra Nagale , Michael C. Larson , Mark Boden
Abstract: In one aspect, the present disclosure is directed to a system and method for ablating tissue. The method may comprise, for example, aligning a needle of a medical device with the target tissue; piercing tissue adjacent to the target tissue with the needle; sliding into the target tissue a laser fiber moveably disposed within the needle, wherein the needle is hollow and the laser fiber includes a prism; and delivering laser energy through the laser fiber and prism.
-
公开(公告)号：US10315005B2
公开(公告)日：2019-06-11
申请号：US15385301
申请日：2016-12-20
Applicant: Boston Scientific Scimed, Inc.
Inventor： Sandra Nagale , David C. Borzelleca , Michael F. Weiser
Abstract: A medical device is disclosed. The medical device may include an elongate member having a proximal end and a distal end an expandable end effector assembly extending distally from the distal end of the elongate member. The end effector assembly may include a plurality of end effector units each having an injector for simultaneously delivering material into tissue.
-
Patent Agency Ranking
公开(公告)号：US20190150851A1
公开(公告)日：2019-05-23
申请号：US16188669
申请日：2018-11-13
Applicant: Boston Scientific Scimed, Inc.
Inventor： Bryan Allen Clark , Elizabeth Mary Annoni , Sandra Nagale , Jeffrey E. Stahmann , Kyle Harish Srivastava , Mark W. Boden , Martin Phelan , George Wilfred Duval
Abstract: An example of a system for monitoring and treating a medical condition of a patient may include signal inputs to receive patient condition signals indicative of a state of inflammatory bowel disease (IBD), a signal processing circuit configured to process the patient condition signals and generate patient condition parameters indicative of the state of IBD using the processed patient condition signals, and a medical condition analyzer configured to analyze the patient condition parameters and determine the medical condition including the state of IBD using an outcome of the analysis. The patient condition parameters may include one or more physiological marker parameters each representative of a physiological marker of IBD and one or more quality of life parameters each being measure of quality of life of the patient.
-
公开(公告)号：US20160346430A1
公开(公告)日：2016-12-01
申请号：US15167209
申请日：2016-05-27
Applicant: Boston Scientific Scimed, Inc.
Inventor： Sandra Nagale , David SHREEVE , Mark BODEN , Jonathan ZOLL , Timothy HARRAH , Steven KANGAS , Kasyap SEETHAMRAJU , Deanna CAVALLARO , Martin PHELAN
CPC classification number: A61L27/20 , A61L27/52 , A61L2400/06 , A61L2430/22 , C08L5/04 , C08L5/00
Abstract: Methods of treating tissue of a patient, e.g., tissue of an organ such that the bladder, are described. The methods may comprise inserting a medical device within the bladder; and injecting a composition to separate a first layer of tissue from a second layer of tissue. The composition may comprise at least one polysaccharide compound having a concentration ranging from approximately 0.05% to approximately 25% by weight, with respect to the total weight of the composition. The composition may at least partially separate the first layer of tissue from the second layer of tissue. At least one of the first layer of tissue or the second layer of tissue may be a detrusor muscle tissue.
Abstract translation: 描述了治疗患者组织的方法，例如器官的组织，使得膀胱。 该方法可以包括在膀胱内插入医疗装置; 以及注射组合物以将组织的第一层与第二组织层分离。 相对于组合物的总重量，组合物可以包含至少一种浓度范围为约0.05重量％至约25重量％的多糖化合物。 组合物可以至少部分地将第一层组织与第二组织层分开。 第一层组织或第二层组织中的至少一个可以是逼尿肌组织。
-
公开(公告)号：US20150025308A1
公开(公告)日：2015-01-22
申请号：US14332100
申请日：2014-07-15
Applicant: Boston Scientific Scimed, Inc.
Inventor： Mark W. Boden , Kasyap Seethamraju , Eric Michael Petersen , Sandra Nagale
CPC classification number: B32B38/0012 , A61B17/0469 , A61B17/0625 , A61B2017/00805 , A61B2017/047 , A61F2/0045 , A61F2250/0018 , Y10T156/1002
Abstract: In one embodiment, an implant includes a body member, a first arm member and a second arm member. The body member is formed of a first material and has a first side portion and a second side portion. The body member has a first stiffness and includes multiple apertures through the body member. The first arm member is formed of a second material and is coupled to and extends from the body member. The second arm member is formed of the second material and is coupled to and extends from the body member. The first arm member and the second arm member have a second stiffness, the second stiffness being more than the first stiffness.
Abstract translation: 在一个实施例中，植入物包括主体构件，第一臂构件和第二臂构件。 本体构件由第一材料形成，并具有第一侧部和第二侧部。 主体构件具有第一刚度并且包括通过主体构件的多个孔。 第一臂构件由第二材料形成并且联接到主体构件并从主体构件延伸。 第二臂构件由第二材料形成并且联接到主体构件并从主体构件延伸。 第一臂构件和第二臂构件具有第二刚度，第二刚度大于第一刚度。
-
公开(公告)号：US11904075B2
公开(公告)日：2024-02-20
申请号：US16504655
申请日：2019-07-08
Applicant: Boston Scientific Scimed, Inc.
Inventor： Sandra Nagale , Mark W. Boden , Andrew Dolan
CPC classification number: A61L31/16 , A61K9/0034 , A61L27/52 , A61L27/54 , A61L31/042 , A61L31/044 , A61L31/045 , A61L31/047 , A61L31/048 , A61L31/06 , A61L31/145 , A61L2400/06
Abstract: In some aspects, the present invention provides surgical procedures that comprise applying compositions into and/or onto tissue, including supporting tissues (e.g., ligaments, connective tissue, muscles, etc.) for pelvic organs, among other tissues. In other aspects, the present disclosure pertains to compositions that are useful for performing such procedures. In still other aspects, the present disclosure pertains to kits that are useful for performing such procedures.
-
公开(公告)号：US11903637B2
公开(公告)日：2024-02-20
申请号：US16890395
申请日：2020-06-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Thomas John Herbst , Mark W. Boden , Sandra Nagale
CPC classification number: A61B18/1485 , A61B18/1477 , A61B18/1492 , A61B18/1815 , A61B18/20 , A61B2018/00434 , A61B2018/00517 , A61B2018/00577 , A61B2018/00595 , A61B2018/0293 , A61B2018/143 , A61B2018/1432 , A61B2018/1475 , A61N7/022 , A61N2007/025
Abstract: In one aspect, the present disclosure is directed to methods of treating various conditions including bladder conditions in a patient, comprising: positioning at least one ablative element of an ablative device on or over an adventitial surface of the bladder; and using the ablative device to denervate bladder nerve fibers. Other aspects of the present disclosure pertain, for example, to devices and kits for of treating bladder conditions.
-
-
-
-
-
-
-
-
-
Search Results
45
records
(took 0.044 seconds)
